MADISON KIRSCH: Open Payments
NPI 1871219923 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 29 payments from 11 companies in 2025. Trend: 2023 $27 · 2024 $2,586 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $153 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Neuronetics, Inc. | 3 | $75 |
| Neurocrine BioSciences, Inc. | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $25 |
Products named: VRAYLAR, Auvelity, NEUROSTAR TMS THERAPY SYSTEM, INGREZZA, Jornay PM, TRINTELLIX, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across ND — which companies pay providers there.
